We are international
Donate
TEXT SIZE   


Dr. Richardson - Elotuzumab In Combination with Lenalidomide and Dexamethasone In Patients with Relapsed Multiple Myeloma: Interim Results of a Phase 2 Study
Paul G. Richardson, MD
Dana-Farber Cancer Institute, Harvard Medical School
Boston, Massachusetts
USA
12.02.10


To view the video full screen, click on the small button next to the volume control in the lower right hand corner.


 related articles